Loading [MathJax]/jax/output/SVG/jax.js
Review

Mast cells, mediators, and symptomatic activation

  • Received: 28 November 2022 Revised: 20 March 2024 Accepted: 26 March 2024 Published: 09 April 2024
  • Mast cells (MC) are central effectors of allergic disease and distinct subsets with varying amounts of tryptase, chymase, and carboxypeptidase A3, and cathepsin G is distributed throughout the body. Their involvement in a diverse range of non-allergic illnesses mediated by a complex range of preformed and newly synthesized mediators is now increasingly recognized. The latter especially include conditions under the umbrella term of mast cell activation syndrome. In allergic disease, much has been written about the mechanisms by which the early and rapidly acting mediators produce both localized and systemic allergic symptoms. The role of chymase is presently underappreciated but there is increased awareness that MCs contain significant amounts of preformed TNF alpha and synthesize and releases a wide range of inflammatory cytokines such as interleukins (IL) 1β, IL6, IL31, and IL33. These can aggravate itching and perpetuate inflammation and likely contribute to the late constitutional symptoms seen in allergic reactions. Importantly, their involvement helps to clarify the role of MCs in stress and non-parasitic infections. Presently, unexplained is the increasing incidence of significant acute allergic reactions within a relatively short time frame. In this context, there is increasing interest in the environmental, menstrual, endocrine, circadian, and psychological factors that influence MC activation as well as the endocrine pathways involving the renin angiotensin system that oppose hypotension. In non-allergic diseases with normal numbers of MCs, reduced thresholds for activation may be produced by various combinations of life and dietary factors. Diagnosing these conditions is difficult but may be helped by urinary analysis of prostaglandin metabolites. The investigation and management of mastocytosis with and without mutations of c-kit is also relevant to allergic disease and the new medications used may also be helpful in idiopathic anaphylaxis. This knowledge may open a new chapter in human diseases and mast cell regulation.

    Citation: Amolak S Bansal, Alex Nicholas, Nazira Sumar, Veronica Varney. Mast cells, mediators, and symptomatic activation[J]. AIMS Allergy and Immunology, 2024, 8(1): 34-55. doi: 10.3934/Allergy.2024004

    Related Papers:

    [1] Luyao Li, Licheng Fang, Huan Liang, Tengda Wei . Observer-based event-triggered impulsive control of delayed reaction-diffusion neural networks. Mathematical Biosciences and Engineering, 2025, 22(7): 1634-1652. doi: 10.3934/mbe.2025060
    [2] Ravi Agarwal, Snezhana Hristova, Donal O’Regan, Radoslava Terzieva . Stability properties of neural networks with non-instantaneous impulses. Mathematical Biosciences and Engineering, 2019, 16(3): 1210-1227. doi: 10.3934/mbe.2019058
    [3] Biwen Li, Yujie Liu . Average-delay impulsive control for synchronization of uncertain chaotic neural networks with variable delay impulses. Mathematical Biosciences and Engineering, 2025, 22(6): 1382-1398. doi: 10.3934/mbe.2025052
    [4] Yawei Shi, Hongjuan Wu, Chuandong Li . Constrained hybrid control for parametric uncertainty systems via step-function method. Mathematical Biosciences and Engineering, 2022, 19(11): 10741-10761. doi: 10.3934/mbe.2022503
    [5] Liqin Liu, Chunrui Zhang . A neural network model for goat gait. Mathematical Biosciences and Engineering, 2024, 21(8): 6898-6914. doi: 10.3934/mbe.2024302
    [6] Haydar Akca, Chaouki Aouiti, Farid Touati, Changjin Xu . Finite-time passivity of neutral-type complex-valued neural networks with time-varying delays. Mathematical Biosciences and Engineering, 2024, 21(5): 6097-6122. doi: 10.3934/mbe.2024268
    [7] Haifeng Huo, Fanhong Zhang, Hong Xiang . Spatiotemporal dynamics for impulsive eco-epidemiological model with Crowley-Martin type functional response. Mathematical Biosciences and Engineering, 2022, 19(12): 12180-12211. doi: 10.3934/mbe.2022567
    [8] Yanjie Hong, Wanbiao Ma . Sufficient and necessary conditions for global attractivity and stability of a class of discrete Hopfield-type neural networks with time delays. Mathematical Biosciences and Engineering, 2019, 16(5): 4936-4946. doi: 10.3934/mbe.2019249
    [9] Haitao Zhu, Xinrui Ji, Jianquan Lu . Impulsive strategies in nonlinear dynamical systems: A brief overview. Mathematical Biosciences and Engineering, 2023, 20(2): 4274-4321. doi: 10.3934/mbe.2023200
    [10] Pan Wang, Xuechen Li, Qianqian Zheng . Synchronization of inertial complex-valued memristor-based neural networks with time-varying delays. Mathematical Biosciences and Engineering, 2024, 21(2): 3319-3334. doi: 10.3934/mbe.2024147
  • Mast cells (MC) are central effectors of allergic disease and distinct subsets with varying amounts of tryptase, chymase, and carboxypeptidase A3, and cathepsin G is distributed throughout the body. Their involvement in a diverse range of non-allergic illnesses mediated by a complex range of preformed and newly synthesized mediators is now increasingly recognized. The latter especially include conditions under the umbrella term of mast cell activation syndrome. In allergic disease, much has been written about the mechanisms by which the early and rapidly acting mediators produce both localized and systemic allergic symptoms. The role of chymase is presently underappreciated but there is increased awareness that MCs contain significant amounts of preformed TNF alpha and synthesize and releases a wide range of inflammatory cytokines such as interleukins (IL) 1β, IL6, IL31, and IL33. These can aggravate itching and perpetuate inflammation and likely contribute to the late constitutional symptoms seen in allergic reactions. Importantly, their involvement helps to clarify the role of MCs in stress and non-parasitic infections. Presently, unexplained is the increasing incidence of significant acute allergic reactions within a relatively short time frame. In this context, there is increasing interest in the environmental, menstrual, endocrine, circadian, and psychological factors that influence MC activation as well as the endocrine pathways involving the renin angiotensin system that oppose hypotension. In non-allergic diseases with normal numbers of MCs, reduced thresholds for activation may be produced by various combinations of life and dietary factors. Diagnosing these conditions is difficult but may be helped by urinary analysis of prostaglandin metabolites. The investigation and management of mastocytosis with and without mutations of c-kit is also relevant to allergic disease and the new medications used may also be helpful in idiopathic anaphylaxis. This knowledge may open a new chapter in human diseases and mast cell regulation.


    Abbreviations

    ACE:

    angiotensin converting enzyme; 

    RAS:

    renin angiotensin system; 

    AII:

    angiotensin-2; 

    AI:

    angiotensin-1; 

    PAF:

    platelet activating factor; 

    eNO:

    endothelial nitric oxide; 

    ATR-1:

    angiotensin-2 receptor; 

    BK:

    bradykinin; 

    BP:

    blood pressure; 

    C5a:

    complement protein C5a; 

    C3a:

    complement protein C3a; 

    mRNA:

    messenger RNA; 

    IgE:

    Immunoglobulin E

    The neural network modeling approach in the form of differential equations has been intensively applied by numerous researchers in different areas of science, engineering and medicine. The construction of a neuronal network model and its analysis are key goals in many practical applications. Indeed, the applications of such models include a variety of problems, such as optimization problems, associative memory, parallel processing, linear and nonlinear programming, including algorithms, computer vision, pattern recognition and many others [1,2].

    The Cohen–Grossberg-type of neural networks [3] are an important class of neural network models that are widely used as a framework in the study of partial memory storage and global pattern formation phenomena [4,5,6]. Due to its important applications, the properties of different Cohen–Grossberg neural network models have been intensively studied, including some very recent results [7,8]. This class of neural networks also generalizes some of the essential neural network models, such as Hopfield neural networks [9] and cellular neural networks [10,11].

    In order to create more adequate neural network models, researchers have generalized and extended the classical Cohen–Grossberg-type of neural networks in different directions. One line of generalization relates to the consideration of the affects of impulsive disturbances on their qualitative behavior. In fact, short-term perturbations are natural for most applications of such neural networks, and their presence may affect the dynamic properties of the models. The apparatus of impulsive differential equations [12,13,14] has been widely applied to develop and investigate impulsive neural network models. Using the impulsive modeling approach, different classes of impulsive Cohen–Grossberg neural networks have been proposed [15,16,17]. The closely related impulsive control approach [18,19] has also been examined effectively [20,21].

    The fractional calculus approach has also been applied in the neural network modeling. Indeed, models with fractional order dynamics generalize the integer-order models and have numerous advantages, including universality, more flexibility and hereditary properties [22,23,24,25]. Numerous researchers contributed to the development of fractional-order Cohen–Grossberg neural network models and the study of their properties [26,27,28,29,30].

    In the development of the fractional calculus fruitful direction of generalization, the most used fractional order derivatives are these of the Grunwald–Letnikov, Caputo and Riemann–Liouville types. Note that there are some restrictions when the above notions are applied to real-world models. Some of the restrictions are related to their properties and mainly to the nonexistence of a straightforward rule for the derivatives of compositions of functions. To overcome such difficulties, several researchers proposed new approaches, such as Caputo–Fabrizio [31], Caputo–Hadamard [32], including variable fractional order derivatives [33,34] without singular kernels, and generated new fractional models.

    One of the recently applied extended fractional calculus approaches is based on the use of the conformable or fractional-like derivatives [35,36] which offer some computational simplifications related to derivatives of compositions of functions. Some interesting and important results for systems with conformable derivatives are proposed in [37,38,39,40]. Physical interpretations of the conformable derivatives have been given in [41,42]. Due to the advantages of such derivatives that are limit based and follow a very simple chain rule, the conformable calculus begins to be used in the modeling of several phenomena studied in economics [43], medicine [44] and forecasting [45].

    The impulsive generalization is also applied to the conformable calculus approach. However, the results in this direction are very few and the theory of impulsive conformable systems is still not completed [46,47,48]. Also, to our best knowledge, the combined impulsive conformable modeling approach has not been applied to Cohen–Grossberg neural network models, and this is the main goal of this article. In fact, the proposed conformable technique seems to be very suitable for neural networks because of the simplifications in calculations offered.

    In practical implementations, the global exponential stability for integer-order models [49,50] and Mittag–Leffler stability for models with fractional dynamics [51,52] are ones of the most important neural network's behaviors. Hence, there are numerous results that provided efficient asymptotic stability, exponential stability and Mittag–Leffler stability criteria for Cohen–Grossberg neural networks [3,5,6,7,15,21,26,27,30]. However, there are also cases when the classical asymptotic and Mittag–Leffler stability strategies cannot be applied [53]. In some of these cases, when the trajectories of a neural network model are not mathematically stable, but the system behavior is admissible from the practical point of view, the concept of practical stability is more relevant [54,55].

    In the past decade, the practical stability concept has been rapidly developed [56,57], and has been extended to the practical stability with respect to manifolds notion [58]. Indeed, the practical stability is useful in many applied systems when the dynamic of the model is contained within particular bounds during a fixed time interval. In such cases, the global asymptotic notion is not applicable. The practical stability strategy is also very efficient when a neuronal state is unstable in the classical sense and yet, state trajectories may oscillate sufficiently near the desired state such that its performance is admissible, which does not imply stability or convergence of trajectories. In addition, there are many applied systems that are stable or asymptotically stable in the classical sense, but actually useless in practice because of the small or inappropriate stability domain or attraction domain. The stability with respect to manifolds concepts are generalizations of the stability notions for single trajectories and are related to the study of stability properties of a manifold of states. Such concepts are of considerable interest to networks capable of approaching not only one steady state. The extended practical stability with respect to manifolds concept has been applied to integer-order Cohen–Grossberg models in [59] and to some conformable models [60]. However, there is no one existing result on practical stability with respect to manifolds for impulsive conformable Cohen–Grossberg neural networks. It is clear that this task is attractive and important in the analysis of such neural network models.

    The main goal of this research is to propose an impulsive conformable Cohen–Grossberg-type neural network model. Also, the adoption of the practical stability with respect to manifolds notion is an essential motivation for our study.

    The innovations of this article can be described as follows:

    (1) We propose a new impulsive conformable Cohen–Grossberg neural network model. The advantages of the conformable modelling approach can be used in the analysis of the properties of the introduced model. The impulsive perturbations can also be used to stabilize and control the proposed model.

    (2) We introduce the practical stability with respect to manifolds notion. Using modifications of the Lyapunov technique, new criteria are proposed, which guarantee the practical stability behavior of manifolds related to the newly suggested model.

    (3) The BAM generalization of the introduced model is analysed, and the corresponding sufficient conditions for practical stability with respect to manifolds are established.

    (4) We verify the efficiency of the established criteria by examples.

    The structuring of the rest of the paper pursue the following scheme. In Section 2 some definitions and lemmas from conformable calculus are given. The conformable impulsive Cohen–Grossberg neural network model is introduced and the practical stability with respect to manifolds concept is adopted to it. Some preliminaries related to the Lyapunov functions method are also given. Section 3 is devoted to the main practical stability results established on the basis of a Lyapunov-type analysis. The case of BAM impulsive conformable Cohen–Grossberg-type neural networks is studied, and sufficient conditions for the practical exponential stability of the trajectories are proposed in Section 4. Illustrative examples are elaborated in Section 5. Some concluding comments are stated in Section 6.

    Notations: R is the set of all real numbers, the set of all nonnegative real numbers will be denoted by R+=[0,), Rn denotes the n-dimensional real space with the norm ||y||=nι=1|yι| of an yRn, y=(y1,y2,,yn)T.

    Here, we will present some basic definitions and lemmas related to the conformable calculus. Let τ0R+.

    Definition 1. [47,48] The generalized conformable derivative of order α, 0<α1 for a function y(t):[˜t,)Rn, ˜tτ0 is defined by

    Dα˜ty(t)=lim{y(t+ϕ(t˜t)1α)y(t)ϕ, ϕ0}.

    Let the time instants τ1,τ2,, are such that

    τ0<τ1<τ2<τk<τk+1<, limkτk=

    and y(τ+k)=lim{y(τk+ϕ), ϕ0+}, y(τk)=lim{y(τkϕ), ϕ0+}.

    For k=1,2,, we have [47,48]

    Dατky(τ+k)=limtτ+kDατky(t),
    Dατk1y(τk)=lim{y(τk+ϕ(τkτk1)1α)y(τk)ϕ, ϕ0}.

    Any function that has an α-generalized conformable derivatives for any t(˜t,) is called α-generalized conformable differentiable on (˜t,), and we will denote the set of all such functions by Cα[(˜t,),Rn] [48].

    Definition 2. [47] Let y:[˜t,)Rn. The generalized conformable integral of order 0<α1 of y is given by

    Iα˜ty(t)=t˜t(o˜t)α1y(o)do.

    The following properties of the generalized conformable derivatives and integrals will be applied in our future analysis [46,47,48].

    Lemma 3. [48] If the function yCα[(˜t,),R] for 0<α1, then

    Iα˜t(Dα˜ty(t))=y(t)y(˜t), t>˜t.

    Lemma 4. [48] Assume that X(y(t)):(˜t,)R and 0<α1. If X() is differentiable with respect to y and yCα[(˜t,),R], then for t[˜t,) and y(t)0, we have

    Dα˜tX(y(t))=X(y(t))Dα˜t(y(t)),

    where X is the derivative of X()

    Remark 5. The result represented in Lemma 5 is a simple chain rule which is not applicable for the classical fractional-order derivatives. More results on the conformable derivatives can be found in [35,36,37,38,39,40,46,47,48].

    Remark 6. To emphasize more advantages of the application of fractional derivatives, we note the following properties for α(0,1] and x,yCα[(˜t,),R] which follow directly by Definition 1 [35,36,41,48]:

    (a) Dα˜t(ax(t)+by(t))=aDα˜t(x(t))+bDα˜t(y(t)) for all a,bR;

    (b) Dα˜t(tp)=ptp1(t˜t)1α for any pR;

    (c) Dα˜t(x(t)y(t))=x(t)Dα˜t(y(t))+y(t)Dα˜t(x(t));

    (d) Dα˜t(x(t)y(t))=y(t)Dα˜t(x(t))x(t)Dα˜t(y(t))y2(t);

    (e) Dα˜t(x(t))=0 for any x(t)=λ, where λ is an arbitrary constant.

    For the classical fractional derivatives [22,23,24,25], including the Riemann-Liouville fractional derivative

    DRL˜tx(t)=ddt[1Γ(1α)t˜tx(s)(ts)αds],

    where 0<α<1 and Γ(z)=0ettz1dt is the Gamma function, and Caputo fractional derivative

    DC˜tx(t)=1Γ(1α)t˜tx(s)(ts)αds

    the properties (b)–(e) do not hold, except for the statement (e) for a fractional derivative of Caputo. The reason for this is the application of the integral in the known definitions of fractional derivatives.

    In this section we propose an impulsive Cohen–Grossberg-type neural network model with generalized conformable derivatives as follows

    {Dατkyι(t)=aι(yι(t))[bι(yι(t))nj=1cιjfj(yj(t))Uι(t)],   tτk, k=0,1,2,yι(τ+k)=yι(τk)+Pιk(yι(τk)), k=1,2,, (1)

    where ι=1,2,,n, n2 represents the number of the units, yι(t) is the state of the ι-th node at time t, the functions aι,bι,fj,UιC[R,R+] and cιjR+, ι,j=1,2,,n are the system's parameters in the continuous part, aι denote the amplification functions, bι are appropriate behaved functions, fj represent the activation functions, Uι denotes the external bias on the ιth node at time t, cιj represent the connection weights, yι(τk)=yι(τk) and yι(τ+k) in the impulsive condition are, respectively, the neuronal states of the ι-th node before and after an impulsive perturbation at τk and the impulsive functions PιkC[R,R] represent the effects of the impulse controls on the node yι at τk, ι=1,2,,n, k=1,2,.

    For τ0R+ we define the initial condition corresponding to the model (1) as

    y(τ+0)=y(τ0)=y0, (2)

    where y0Rn.

    A function φRn that satisfies the system (1) and the initial condition (2) will be called a solution of the initial value problem (1), (2), and will be denoted by φ(t)=φ(t;τ0,y0), where φ(t)=(φ1(t),φ2(t),,φn(t))T.

    According to the theory of impulsive conformable systems [46,47,48], the solution φ(t) of the initial value problem (1), (2) is an α-generalized conformable differentiable function, which is piecewise continuous with points of discontinuity of the first kind τk, k=1,2,, at which it is left continuous. At the impulsive moments, the functions φ(t) is such that

    φι(τk)=φι(τk), φι(τ+k)=φι(τk)+Pιk(φι(τk)), ι=1,2,,n, k=1,2,. (3)

    The set of all such functions will be denoted by PCα[R+,Rn].

    For example, for the solution of an impulsive scalar generalized conformable neural network of the type

    {Dατku(t)=a(t)u(t)a(t)b(t), ttk, k=0,1,,u(τ+k)=u(τk)+pku(τk), k=1,2,, (4)

    where uR, a,bC[R+,R+], pkR, k=1,2,, we obtain

    u(t)=u(τ+0)kj=1(1+pj)exp{tτka(o)(oτk)1αdo+kl=1τlτl1a(o)(oτl1)1αdo}
    tτkexp{tτka(o)(oτk)1αdosτka(s)(sτk)1αds}a(o)b(o)(oτk)1αd0
    kl=1kj=l(1+pj)τlτl1exp{tτka(o)(oτk)1αdooτl1a(s)(sτl1)1αds
    +km=lτmτm1a(o)(oτm1)1αdo}a(o)b(o)(oτl1)1αdo.

    We will study some stability properties of the introduced model (1) under the following hypotheses:

    H1. The continuous functions aιR+, ι=1,2,,n are such that there exist positive constants a_ι and ¯aι for which 1<a_ιaι(χ)¯aι for χR, and a_=min1ιnaι, ¯a=max1ιnaι.

    H2. The continuous functions bιR+ are such that there exist constants βι>0 with

    bι(χ)βι|χ|,

    for any χR and ι=1,2,,n.

    H3. There exist Lipschitz constants Lfj>0 such that

    |fj(χ1)fj(χ2)|Lfj|χ1χ2|, fj(0)=0

    for all χ1,χ2R, j=1,2,,n.

    Remark 7. The developed Cohen–Grossberg type model (1) with generalized conformable derivatives is an extension of the existing integer-order neural network models studied in [3,5]. It also extends some impulsive models investigated in [15,16,17,20,21] to the conformable setting. Since the concept of the conformable derivative overcomes some limitations related to the classical fractional-order derivatives, the introduced model is more suitable for applications than the models considered in [26,27,29,30]. In addition, considering impulsive perturbations will allow for the application of efficient impulsive control strategies [18,19,20,21,58,59].

    In order to apply the practical stability with respect to manifolds method [55,58,59] to the model (1), we consider a continuous function H:[τ0,)×RnRm, H=(H1,H2,,Hm)T, mn which defines the following (nm)-dimensional manifold:

    MHt={yRn: H1(t,y)=H2(t,y)==Hm(t,y)=0, t[τ0,)}. (5)

    The defined above manifold, will be called a H-manifold.

    Consider, also

    MHt(ε)={yRn: ||H(t,y)||<ε, t[τ0,)}, ε>0,

    and adopt the following notions [55,56,57,58,59].

    Definition 8. If for given (λ,A) with 0<λ<A, y0MHτ0(λ) implies y(t;τ0,y0)MHt(A), tτ0 for some τ0R+, then the manifold MHt is said to be practically stable for the model (1).

    Definition 9. If for given (λ,A) with 0<λ<A, y0MHτ0(λ) implies

    y(t;τ0,y0)MHt(A+μ||H(τ0,y0)||Eα(δ,tτ0)),tτ0, for some τ0R+,

    where 0<α<1, μ,δ>0, and Eα(ν,o) is the conformable exponential function given as [47]

    Eα(ν,o)=exp(νoαα), νR, oR+.

    then the manifold MHt is said to be practically exponentially stable for the model (1).

    Remark 10. Definitions 8 and 9 generalize and extend the classical stability notions to the combined practical stability with respect to manifolds case. The combined setting increases the benefits of both approaches. In some particular cases, the defined concept can be reduced to simple practical stability notions that are used widely in the applied problems [60,61,62,63]. For example, if the function that defines the manifold H(t,y)=0 only for y=0, then definitions 8 and 9 are the classical definitions of practical stability and exponential practical stability of the zero solution of the model (1), respectively. Similarly, if the manifold MHt includes only an equilibrium state y, i.e., H(t,y)=0, then the above definitions are reduced to the practical stability and exponential practical stability definitions of y, respectively. Other particular cases, such as practical stability and exponential practical stability of periodic and almost periodic solutions can be considered analogously. Thus, the proposed practical stability with respect to manifolds technique offers a high-powered mechanism which can be applied not only for single solutions, but also in the cases when manifolds of solutions are attractors for the models. This technique is also appropriate to investigate such manifolds that are not stable in the classical Lyapunov sense, but their dynamic is acceptable from the practical point of view [55,58].

    We will also need the following additional hypothesis related to the specifics of the stability with respect to manifolds concepts.

    H4. Each solution y(t;τ0,y0) of the initial value problem (1), (2) such that

    ||H(t,y(t;τ0,y0))||Ω<,

    where Ω>0 is a constant, is defined on [τ0,).

    Consider the sets Gk=(τk1,τk)×Rn, k=1,2,, G=k=1Gk.

    In the further study, we apply a modified conformable Lyapunov function approach. A class of Lyapunov-like functions Lατk is defined as [47] a set of functions L(t,y):GR+ that are continuous on G, α-generalized conformable differentiable in t, locally Lipschitz continuous with respect to y on each of the sets Gk, L(t,0)=0 for tτ0, and for each k=1,2, and yRn, there exist the finite limits

    L(τk,y)=limtτkt<τkL(t,y),L(τ+k,y)=limtτkt>τkL(t,y),

    with L(τk,y)=L(τk,y).

    For a function LLατk, the upper right conformable derivative is defined by [47]

    +Dατk L(t,y)=lim sup{L(t+ϕ(tτk)1α, y(t+ϕ(tτk)1α))L(t,y)ϕ, ϕ0+}. (6)

    Denote by F(t,y)=(F1(t,y),F2(t,y),,Fn(t,y))T, where y=(y1,y2,,yn)T and

    Fι(t,y)=aι(yι)[bι(yι)nj=1cιjfj(yj)Uι(t)]

    for ι=1,2,,n.

    Then, the generalized conformable derivative of the function L(t,y) with respect to system (1), (2) is [47]

    +Dατk L(t,y)(1)=lim sup{L(t+ϕ(tτk)1α, y+ϕ(tτk)1αF(t,y))L(t,y)ϕ, ϕ0+}. (7)

    If L(t,y(t))=L(y(t)), 0<α1, the function L is differentiable on y, and the function y(t) is α-generalized conformable differentiable on [τ0,), then Lemma 4 can applied componentwise.

    It follows from (6) and (7) that

    +Dατk L(t,y(t;τk,yk))=+Dατk L(t,y)(1),

    where yk=y(τ+k), k=0,1,2,.

    For more information about the conformable modifications of the Lyapunov functions approach for impulsive control models, we refer to [46,47,48].

    The next Lemma from [47] will be also necessary.

    Lemma 11. If for the function LLατk and for t[τ0,), yRn, we have:

    (i)

    L(τ+k,y)L(τk,y),  k=1,2,,

    (ii)

    +Dατk L(t,y)δL(t,y)+ϱ(t), tτk, k=0,1,

    for δ=const>0, ϱ Cα[R,R+], then

    L(t,y(t))L(τ+0,y0)Eα(δ,tτ0)+tτkWα(tτk,oτk)ϱ(o)(oτk)1αdo
    +kj=1 kl=kj+1Eα(δ,τlτl1)τkj+1τkjWα(tτk,oτkj)ϱ(o)(oτkj)1αdo, tτ0,

    where Wα(tτk,oτk)=Eα(δ,tτk)Eα(δ,oτk), 0<α<1, k=0,1,2,.

    In this Section, we will apply the modified conformable Lyapunov-function approach to establish our main practical stability with respect to the manifold MHt criteria for the conformable impulsive Cohen–Grossberg neural network model (1).

    Theorem 12. Assume that 0<λ<A, hypotheses H1–H4 hold and:

    (i) there exists a function H:[τ0,)×RnRm, mn, such that

    ||H(t,y)||||y||Γ(Ω)||H(t,y)||, (t,y)[τ0,)×Rn, (8)

    where Γ=Γ(Ω) is a constant, Γ(Ω)1, Γ(Ω)λ<A for any 0<Ω<;

    (ii) the parameters and the impulsive control functions of the impulsive conformable Cohen–Grossberg neural network model (1) satisfy:

    min1ιn(a_ιβι¯aιLfιnj=1cjι)>0, (9)
    Uι(t)=0, t[τ0,), ι=1,2,,n, (10)
    Pιk(yι(τk))=γιkyι(τk), 0γιk2, ι=1,2,,n, k=1,2,. (11)

    Then, the manifold MHt is practically stable for the model (1).

    Proof. For the given 0<λ<A and y0Rn let suppose that y0MHτ0(λ) and consider the solution y(t;τ0,y0) of the impulsive conformable Cohen–Grossberg model (1) corresponding to the initial condition (2).

    We construct a Lyapunov-type function as

    L1(t,y)=||y(t)||=nι=1|yι(t)|. (12)

    From condition (11) of Theorem 12, at the impulsive control instants t=τk, k=1,2,, we have:

    L1(τ+k,y(τ+k))=nι=1|yι(τk)+Pιk(yι(τk))|=nι=1|1γιk||yι(τk)|
    nι=1|yι(τk)|=L1(τk,y(τk)), (13)

    for k=1,2,.

    From H1-H3 and conditions (9) and (10) of Theorem 12, for tτk, k=0,1,2,, we obtain:

    +Dατk L1(t,y(t))nι=1[a_ιβι|yι(t)|+¯aιnj=1cijLfj|yι(t)|]
    min1ιn(a_ιβι¯aιLfιnj=1cjι)L1(t,y(t))0. (14)

    Now, from (13) and (14), according to Lemma 11 for δ=ϱ(t)=0, t[τ0,), we have

    L1(t,y(t;τ0,y0))L1(τ+0,y0), tτ0.

    Hence, from condition (8) of Theorem 12, we obtain

    ||H(t,y(t;τ0,y0))||||y(t;τ0,y0)||||y0||Γ(Ω)||H(t,y0)||<Γ(Ω)λ<A, (15)

    and, therefore, the manifold MHt is practically stable for the model (1).

    Next, criteria for the practical exponential stability of the manifold MHt for the model (1) will be presented.

    Theorem 13. Assume that 0<λ<A, hypotheses H1–H4 hold and:

    (i) there exists a function H:[τ0,)×RnRm, mn, which satisfies (8) for Γ(Ω)1 any 0<Ω<;

    (ii) condition (11) of Theorem 12 holds and there exists a positive δ1 such that

    min1ιn(a_ιβι¯aιLfιnj=1cjι)δ1>0, (16)

    and

    V1(t)=τ0Wα(tτk,oτk)(oτ0)1αnι=1¯aιUι(o)do
    +kj=1 kl=kj+1Eα(δ,τlτl1)τkj+1τkjWα(tτk,oτkj)(oτkj)1αnι=1¯aιUι(o)do<. (17)

    Then the manifold MHt is practically exponentially stable for the model (1).

    Proof. For the given 0<λ<A and y0Rn let again suppose that y0MHτ0(λ) and consider the solution y(t;τ0,y0) of the impulsive conformable Cohen–Grossberg model (1) corresponding to the initial condition (2). Without loss generality, we can consider 1<λ<V1(t)<A, t[τ0,).

    Consider again the Lyapunov-type function (12).

    Following the same reasoning as in the proof of Theorem 12, at the impulsive control instants t=τk, k=1,2,, we obtain (13).

    Using H1–H3 and conditions (16) of Theorem 13, for tτk, k=0,1,2,, we have

    +Dατk L1(t,y(t))nι=1[a_ιβι|yι(t)|+¯aιnj=1cijLfj|yι(t)|+¯aιUι(t)]
    min1ιn(a_ιβι¯aιLfιnj=1cjι)L1(t,y(t))+nι=1¯aιUι(t)δ1L1(t,y(t))+ϱ1(t), (18)

    where ϱ1(t)=nι=1¯aιUι(t).

    Now, from (13) and (18), using again Lemma 11, we have

    L1(t,y(t;τ0,y0))L1(τ+0,y0)Eα(δ1,tτ0)+V1(t), tτ0.

    Hence, from condition (i) of Theorem 13 and (17), and from the choice of the function L1Lαk, we have

    ||H(t,y(t;τ0,y0))||L1(t,y(t;τ0,y0))
    <A+Γ(Ω)||H(τ+0,y0)||Eα(δ1,tτ0),tτ0.

    Therefore,

    y(t;τ0,y0)MHt(A+Γ(Ω)||H(τ0,y0)||Eα(δ1,tτ0),tτ0, for some τ0R+,

    which implies that the manifold MHt is practically exponentially stable for the model (1).

    In the next result, we will use a different Lyapunov function in order to establish more relaxed sufficient conditions for the parameters in the continuous part of model (1). The price is, more restrictive conditions for the jump functions.

    Theorem 14. Assume that 0<λ<A, hypotheses H1–H4 hold and:

    (i) there exists a function H:[τ0,)×RnRm, mn, such that

    ||H(t,y)||nι=1yι(t)0sgn(o)aι(o)doΓ(Ω)||H(t,y)||, (t,y)[τ0,)×Rn, (19)

    where Γ(Ω)1 for any 0<Ω<;

    (ii) there exists a positive δ such that the parameters and the impulsive control functions of the impulsive conformable Cohen–Grossberg neural network model (1) satisfy:

    a_min1ιn(βιLfιnj=1cjι)δ>0, (20)
    Pιk(yι(τk))=ηιkyι(τk), |1ηιk|a_¯a, ι=1,2,,n, k=1,2,, (21)

    and

    V(t)=τ0Wα(tτk,oτk)(oτ0)1αnι=1Uι(o)do
    +kj=1 kl=kj+1Eα(δ,τlτl1)τkj+1τkjWα(tτk,oτkj)(oτkj)1αnι=1Uι(o)do<. (22)

    Then the manifold MHt is practically exponentially stable for the model (1).

    Proof. Let 0<λ<A. No generality is lost by making the assumption 1<λ<U(t)<A, t[τ0,).

    We construct a new Lyapunov-type function as

    L(t,y)=nι=1yι(t)0sgn(o)aι(o)do, (23)

    for which, we have

    1¯a||y(t)||L(t,y(t))1a_||y(t)||, t[τ0,) (24)

    for any solution y(t)=y(t;τ0,y0) of the impulsive conformable Cohen–Grossberg model (1) corresponding to the initial condition (2) with y0MHτ0(λ).

    From (21) and (24), at the impulsive control instants t=τk, k=1,2,, we have:

    L(τ+k,y(τ+k))1a_||y(τ+k)||=1a_nι=1|yι(τk)+Pιk(yι(τk))|
    =1a_nι=1|1ηιk||yι(τk)|1¯anι=1|yι(τk)|=1¯a||y(τk)||L(τk,y(τk)), (25)

    for k=1,2,.

    Using H1–H3, (20) and (24) from the choice of the function LLαk for tτk, k=0,1,2,, we have

    +Dατk L(t,y(t))nι=1[βι|yι(t)|+nj=1cijLfj|yι(t)|+Uι(t)]
    min1ιn(βιLfιnj=1cjι)||y(t)||+nι=1Uι(t)
    a_min1ιn(βιLfιnj=1cjι)L(t,y(t))+nι=1Uι(t)δL(t,y(t))+ϱ(t), (26)

    where ϱ(t)=nι=1Uι(t).

    Now, from (25) and (26), using again Lemma 11, we have

    L(t,y(t;τ0,y0))L(τ+0,y0)Eα(δ,tτ0)+V(t), tτ0.

    Hence, from condition (i) of Theorem 14 and (22), we have

    ||H(t,y(t;τ0,y0))||L(t,y(t;τ0,y0))
    <A+Γ(Ω)||H(τ+0,y0)||Eα(δ,tτ0),tτ0.

    Therefore,

    y(t;τ0,y0)MHt(A+Γ(Ω)||H(τ0,y0)||Eα(δ,tτ0),tτ0, for some τ0R+,

    which implies that the manifold MHt is practically exponentially stable for the model (1).

    Following the same steps as in the proof of Theorem 14, we can establish the following practical stability criteria.

    Corollary 15. If in Theorem 14 condition (20) is replaced by

    a_min1ιn(βιLfιnj=1cjι)>0 (27)

    and condition (22) is replaced by condition (10) of Theorem 12, then the manifold MHt is practically stable for the model (1).

    Remark 16. The results in this section generalize and extend many existing stability results for integer-order Cohen–Grossberg neural network models [3,4,5,6,7,8], impulsive Cohen–Grossberg neural network models [15,16,17], as well as, Cohen–Grossberg neural network models with classical fractional-order derivatives [26,27,29,30] to the generalized impulsive conformable setting. Also, since the concept of practical stability with respect to manifolds is more general, results on practical stability, stability with respect to manifolds, stability and practical stability of a single solution can be obtained as corollaries. Thus, the proposed results are very general and include many particular stability notions. For example, if in Definition 9, A=0 and the manifold MHt consists only of a single solution y, Theorems 13 and 14 offered criteria for exponential stability of the solution y of the impulsive conformable Cohen–Grossberg neural network model (1).

    Remark 17. The proposed stability of manifold results are also consistent with the results in the pioneering work of Cohen and Grossberg [3], where models capable of approaching infinitely many equilibrium points in response to arbitrary initial data, have been considered.

    Remark 18. The impulsive functions Pιk, ι=1,2,,n, k=1,2, are the impulsive control functions in the introduced model (1). The suitable choice of these functions is crucial for the elaboration of effective impulsive control strategies that can be applied to the trajectories of the model to control their stability properties. Hence, our results contribute to the development of this direction of research. Indeed, the impulsive conformable Cohen–Grossberg neural network model (1) can be considered as a closed-loop control system represented as

    Dατkyι(t)=aι(yι(t))[bι(yι(t))nj=1cιjfj(yj(t))Uι(t)]+uι(t), t>τ0,

    where

    uι(t)=k=1Pιk(yι(t))δ(tτk), ι=1,2,...,n

    is the control input, δ(t) is the Dirac impulsive function. The controller u(t)=(u1(t),...,un(t))T has an effect on sudden change of the states of (1) at the time instants τk where each state yι(t) changes from the position yι(τk) into the position yι(τ+k), Pιk are the functions that characterize the magnitudes of the impulse effects on the units yι at the moments τk, i.e., u(t) is an impulsive control of the conformable model without impulses

    Dατkyι(t)=aι(yι(t))[bι(yι(t))nj=1cιjfj(yj(t))Uι(t)], t>τ0.

    Therefore, our stability results also presents a general design method of impulsive control law u(t) for the impulse free conformable Cohen–Grossberg neural network model. The constants γιk in condition (ii) of Theorem 12 characterize the control gains of synchronizing impulses. Hence, our results can be used to design impulsive control law under which the controlled neural networks of type (1) are practically (practically exponentially) synchronized onto systems without impulses.

    BAM neural networks have attracted an increased interest of numerous researchers since their introduction by Kosko [61,62], due mainly to their important applications in many areas. Some typical applications are related to associative phenomena in two-layer hetero-associative circuits existing in biology, medicine, engineering and computer sciences.

    Significant progress has been made in the theory and applications of different classes of integer-order BAM Cohen–Grossberg neural networks [63,64], including impulsive models [21,65,66]. A practical stability analysis has also been proposed for some integer-order BAM Cohen–Grossberg neural network models [67].

    Correspondingly, there are not reported results in the existing literature on BAM Cohen–Grossberg neural networks with conformable derivatives. In this Section, we will propose results on practical stability of such models with respect to manifolds as corollaries of the results offered in Section 3.

    We consider the following BAM Cohen–Grossberg neural network model with conformable derivatives

    {Dατkyι(t)=aι(yι(t))[bι(yι(t))Nj=1cjιfj(zj(t))Uι(t)],   tτk, k=0,1,2,Dατkzj(t)=aj(zj(t))[bj(zj(t))nι=1cιjfι(yι(t))Uj(t)],   tτk, k=0,1,2,yι(τ+k)=yι(τk)+Pιk(yι(τk)), k=1,2,,zj(τ+k)=zj(τk)+Pjk(zj(τk)), k=1,2,, (28)

    where tτ0, yι(t) and zj(t) represent the states of the ιth neuron in the first Y layer and jth neuron in the second Z-layer, respectively, at time t, fj, fι are the activation functions, aι, aj represent the amplification functions, bι, bj denote well behaved functions, cjι, cιj are the connection weights, the continuous functions Uι, Uj are external inputs, ι=1,2,,n, j=1,2,,N. The impulsive functions Pιk,PjkC[R,R] represent the effects of the impulse controls on the nodes yι and zj, respectively, at τk, ι=1,2,,n, j=1,2,,N, k=1,2,.

    Following the definitions of solutions of the one layer Cohen–Grossber model (1) will denote by u(t), u(t)=(y(t),z(t)), where y(t)=y(t;τ0,y0), z(t)=z(t;τ0,z0) the solution of the BAM neural network model (28) that satisfies the initial conditions:

    y(τ+0)=y(τ0)=y0,  z(τ+0)=z(τ0)=z0, (29)

    where y0Rn, z0RN and u0=(y0,z0)Rn+N.

    We will apply the practical stability notion with respect to a H-manifold

    MHt={uRn+N: H1(t,u)=H2(t,u)==Hm(t,u)=0,t[τ0,)} (30)

    defined by a function H=H(t,u), H:[τ0,)×Rn+NRm, using the following definition.

    Definition 19. The manifold MHt is called practically exponentially stable for the model (28) if given (λ,A) with 0<λ<A, u0MHτ0(λ) implies

    u(t;τ0,u0)MHt(A+μ||H(τ0,u0)||Eα(δ,tτ0)),tτ0, for some τ0R+,

    where 0<α<1, μ,δ>0.

    For the BAM neural network model (28) we can use the demonstrated Lyapunov function approach in Section 3, and obtain similar results. For example, as a corollary of Theorem 14, we can establish the following practical exponential stability criteria for the manifold MHt of the system (28).

    Theorem 20. Assume that 0<λ<A, hypotheses H1–H4 and conditions (20), (21) of Theorem 14 hold and:

    (i) the continuous functions ajR+, j=1,2,,N are such that there exist positive constants a_j and ¯aj for which 1<a_jaj(χ)¯aj for χR, and a_=min1jNaj, ¯a=max1jNaj;

    (ii) the continuous functions bjR+ are such that there exist constants βj>0 with

    bj(χ)βj|χ|,

    for any χR and j=1,2,,N;

    (iii) there exist Lipschitz constants Lfj>0 such that

    |fj(χ1)fj(χ2)|Lfj|χ1χ2|, fj(0)=0

    for all χ1,χ2R, j=1,2,,N;

    (iv) there exists a function H:[τ0,)×Rn+NRm, mn, such that

    ||H(t,u)||nι=1yι(t)0sgn(o)aι(o)do+Nj=1zj(t)0sgn(o)aj(o)do
    Γ(Ω)||H(t,u)||, (t,u)[τ0,)×Rn+N,

    where Γ(Ω)1 for any 0<Ω<;

    (v) each solution u(t)=(y(t),z(t)), y(t)=y(t;τ0,y0), z(t)=z(t;τ0,z0), of the initial value problem (28), (29) such that

    ||H(t,u(t))||Ω<

    is defined on [τ0,);

    (vi) there exists a positive δ such that the parameters and the impulsive control functions of the impulsive conformable Cohen–Grossberg neural network model (28) satisfy:

    a_min1jN(βjLfjnι=1cιj)δ>0, (31)
    Pjk(zj(τk))=ηjkzj(τk), |1ηjk|a_¯a, j=1,2,,N, k=1,2,, (32)

    and

    S(t)=τ0Wα(tτk,oτk)(oτ0)1α(nι=1Uι(o)+Nj=1Uj(o))do
    +kj=1 kl=kj+1Eα(δ,τlτl1)τkj+1τkjWα(tτk,oτkj)(oτkj)1α(nι=1Uι(o)+Nj=1Uj(o))do<. (33)

    Then the manifold MHt is practically exponentially stable for the model (28).

    Remark 21. As a Corollary of Theorem 14, Theorem 20 proposes criteria for practical exponential stability of a manifold for the BAM impulsive conformable Cohen–Grossberg model (28). Similarly, criteria for practical stability of the manifold MHt can be established as a Corollary of Theorem 12.

    In this section, examples are constructed to illustrate the usefulness of the proposed results.

    Example 22. We consider the 2-dimensional impulsive Cohen–Grossberg-type neural network model with generalized conformable derivatives

    {Dαtky1(t)=a1(y1(t))[b1(y1(t))2j=1c1jfj(yj(t))U1(t)],   tτk, k=0,1,2,Dαtky2(t)=a2(y2(t))[b2(y2(t))2j=1c2jfj(yj(t))U2(t)],   tτk, k=0,1,2,y1(τ+k)=y1(tk)8,k=1,2,,y2(τ+k)=y2(tk)6,k=1,2,, (34)

    where α=0.98, t>0, 0=τ0<τ1<τ2<, k=1,2,, limkτk=, fj(yj)=12(|yj+1||yj1|), U1(t)=sint, U2(t)=1, b1(y1)=3y1, b2(y2)=2y2,

    (cij)=(c11c12c21c22)=(1.51.11.30.1).

    (A) If in the model (34), we have a1(y1)=20.5sin(y1), a2(y2)=20.6cos(y2), then hypotheses H1–H3 are satisfied for

    a_1=1.5,¯a1=2.5,a_2=1.4,¯a2=2.6,a_=1.4,¯a=2.6,β1=3,β2=2,Lf1=Lf2=1.

    Also, conditions (20), (21) and (22) of Theorem 14 are satisfied for

    a_min1ι2(βιLfι2j=1cjι)=0.56δ>0,
    |1η1k|=18=0.125a_¯a=0.538, |1η12k|=16=0.167a_¯a=0.538, k=1,2,,

    and ϱ(t)=1+sint.

    If we consider a manifold

    MHt={yR2:H1=H2=0}, (35)

    containing the zero solution y=(0,0)T of the model (34), defined by a function H:R2R2, H=(H1,H2)T, then according to Theorem 14 the manifold (35) is practically exponentially stable for the model (34). The graphs of the trajectories of the model (34) with corresponding fixed τk are shown in Figure 1.

    Figure 1.  The graphs of the practically exponentially stable trajectories of the model (34) for y0=(y01,y02)T=(12,12)T and corresponding fixed τk: (a) the trajectory of y1(t); (b) the trajectory of y2(t).

    Note that for the particular choice of the parameters, condition (16) of Theorem 13 is not satisfied, since

    min1ι2(a_ιβι¯aιLfι2j=1cjι)=2<0.

    Hence, the criteria provided by Theorem 13 for the parameters in the continuous part are more restrictive.

    (B) If in the model (34), we have a1(y1)=a2(y2)=1.4, then, hypotheses H1–H3 are satisfied for

    a_1=¯a1=a_2=¯a2=a_=¯a=1.4,β1=3,β2=2,Lf1=Lf2=1.

    In this case, conditions of Theorem 13 and Theorem 14 are satisfied for δ=δ1=0.56>0. Therefore, the practical exponential stability of the manifold (35) can be provided by either one of the results.

    (C) If in the model (34), we have

    η1k=0.3,

    then condition (21) of Theorem 14 is not satisfied, however, condition (11) of Theorem 12 holds. Hence, in this case we can make some conclusions about the practical exponential behavior of the manifold (35) only by means of Theorem 12.

    In addition, if

    ηιk=1, ι=1,2, k=1,2,,

    then no one of the conditions about the impulsive functions in theorems 13 and 14 are not true, and we cannot make any conclusion about the practical exponential behavior of the manifold (35).

    Remark 23. The demonstrated Example 22 illustrates the validity of theorems 13 and 14 for practical exponential stability of a manifold with respect to an impulsive conformable Cohen–Grossberg neural network model of the type (1). Similar demonstration for the practical stability behavior can be provided for a particular choice of the model's parameters. We show that the conditions for the parameters in the continuous part in Theorem 14 are more relaxed than these in Theorem 13. Also, we demonstrate that the choice of the impulsive functions is very important to control the practical stability behavior of manifolds related to models of type (1).

    Example 24. Consider the BAM Cohen–Grossberg impulsive conformable neural network model (28) with n=N=2, α=0.93, where t>0,

    y(t)=(y1(t)y2(t)),z(t)=(z1(t)z2(t)),U1=U2=U1=U2=1,
    a1(y1)=a2(y2)=a1(z1)=a2(z2)=1.1,bι(yι)=4yι,bj(zj)=4zj,
    fι(yι)=|yι+1||yι1|2,fj(zj)=|zj+1||zj1|2,ι=1,2, j=1,2,
    (cιj)2×2=(c11c12c21c22)=(1.31.51.11.4), (cjι)2×2=(c11c12c21c22)=(1.41.31.21.1),

    with impulsive perturbations of the type

    y(τ+k)y(τk)=(1+13k001+13k)y(τk),k=1,2,,z(τ+k)z(τk)=(1+14k001+14k)z(τk),k=1,2,, (36)

    0=τ0<τ1<τ2<, k=1,2,, limkτk=.

    We can verify that all assumptions of Theorem 20 are satisfied for

    Lf1=Lf2=1,Lf1=Lf2=1,β1=β2=β1=β2=4,a_1=¯a1=a_2=¯a2=a_=¯a=1.1a_1=¯a1=a_2=¯a2=a_=¯a=1.1,δ=1.32,δ=1.43,ηιk=113k,ηjk=114k,ι,j=1,2, k=1,2,.

    Therefore, according to Theorem 20, we conclude that the manifold

    MHt={uR4:H1=H2=H3=H4=0}, (37)

    defined by a function H:R4R4, H=(H1,H2,H3,H4)T=(y1y1,y2y2,z1z1,z2z2)T, where u=(y1,y2,z1,z2)T is a solution of the model (28), is practically exponentially stable for the model (28).

    In this paper, using the impulsive generalization of the conformable calculus approach, an impulsive conformable Cohen–Grossberg neural network model is proposed. The introduced model extends and complements numerous existing integer-order Cohen–Grossberg neural network models [3,4,5,6,7,8], impulsive Cohen–Grossberg neural network models [15,16,17] as well as Cohen–Grossberg neural network models with classical fractional-order derivatives [26,27,29,30] to the generalized impulsive conformable setting. The proposed model possesses the flexibility of the fractional-order models. Moreover, since the conformable derivatives simplify the computational procedures, it overcomes some limitations existing in the applications of the classical fractional-order problems. We adopt the combined concept of practical stability with respect to manifolds to the introduced model. Using a Lyapunov-based analysis, sufficient conditions are derived to ensure the practical stability and practical exponential stability with respect to manifolds. The case of BAM impulsive conformable Cohen–Grossberg neural network models is also studied to contribute to the development of the stability and control theories. Two illustrative examples are given to demonstrate the effectiveness of the contributed results. The application of the proposed conformable calculus approach to more neural network models is an interesting and challenging topic for future research. Also, it is possible to extend the proposed results to the delayed case and study the delay effects on the qualitative behavior of the neuronal states. In fact, delay effects are unavoidable in most of the neuronal network models. In addition, time delays, also known as transmission delays, may affect the dynamical properties of neural networks.

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

    The authors declare there is no conflict of interest.



    Conflict of interest



    All authors declare no conflicts of interest in this paper.

    [1] Bjornsson HM, Graffeo CS (2010) Improving diagnostic accuracy of anaphylaxis in acute care setting. West J Emerg Med 11: 456-461.
    [2] Tejeclor A, Lonson MA, Moromoro M, et al. (2014) Epidemiology of anaphylaxis. Clin Exp Allergy 45: 1027-1039. https://doi.org/10.1111/cea.12418
    [3] Mullins RJ, Wainstein BK, Barnes EH, et al. (2016) Increases in anaphylaxis fatalities in Australia from 1997–2013. Clin Exp Allergy 46: 1099-1110. https://doi.org/10.1111/cea.12748
    [4] Sheikh A, Alves B (2001) Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clin Exp All 31: 1571-1576. https://doi.org/10.1046/j.1365-2222.2001.01203.x
    [5] Braganza SC, Acworth JP, McKinnon DRL, et al. (2006) Paediatric emergency department anaphylaxis: different patterns from Adults. Arch Dis Child 91: 159-163. https://doi.org/10.1136/adc.2004.069914
    [6] Macdougall CF, Cart AJ, Clover AF (2002) How dangerous is food allergy in childhood? The incidence of severe and fatal allergic reactions across UK and Ireland. Arch Dis Child 86: 236-237. https://doi.org/10.1136/adc.86.4.236
    [7] Vetander M, Protudjer JLP, Liija G, et al. (2016) Anaphylaxis to foods in a population of adolescents: incidence, characteristics and associated risks. Clin Exp Allergy 46: 1575-1587. https://doi.org/10.1111/cea.12842
    [8] Terr AI (1985) Anaphylaxis. Clin Rev Allergy 3: 3-23. https://doi.org/10.1007/BF02993040
    [9] Delage C, Irey NS (1972) Anaphylactic deaths: a Clinicopathologic study of 43 cases. J Forensic Sci 17: 525-540. https://doi.org/10.1520/JFS10141J
    [10] Greenberger PA, Rotskoff BD, Lifschultz B (2007) Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 98: 252-257. https://doi.org/10.1016/S1081-1206(10)60714-4
    [11] Smith PK, Hourihane JO, Lieberman P (2005) Risk multipliers for severe food anaphylaxis. World Allergy Organ J 8: 30. https://doi.org/10.1186/s40413-015-0081-0
    [12] Pumphrey R, Stanworth SJ (1996) The clinical spectrum of anaphylaxis in north-west England. Clin Exp All 26: 1364-1370. https://doi.org/10.1111/j.1365-2222.1996.tb00537.x
    [13] Pumphrey RS (2000) Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 30: 1144-1150. https://doi.org/10.1046/j.1365-2222.2000.00864.x
    [14] Reber LL, Hernandez JD, Galli SJ (2007) The pathophysiology of anaphylaxis. J Allergy Clin Immunol 140: 335-348. https://doi.org/10.1016/j.jaci.2017.06.003
    [15] Gupta R, Sheikh A, Strachan DP (2007) Time trends in allergic disorders in the UK. Thorax 62: 91-96. https://doi.org/10.1136/thx.2004.038844
    [16] Berlin MC (2015) Pathogenesis of IgE mediated food allergy. Clin Exp Allergy 45: 1483-1496. https://doi.org/10.1111/cea.12598
    [17] Harper NJN, Cook TM, Garcez T, et al. (2018) Anaesthesia, surgery and life-threatening allergic reactions: Management and outcomes in the 6th National Audit Project (NAP6). Br J Anaesth 121: 159-171. https://doi.org/10.1016/j.bja.2018.04.015
    [18] Sato T, Morishita S, Horie T, et al. (2019) Involvement of premacular mast cells in the pathogenesis of macular diseases. PLoS One 14: e0211438. https://doi.org/10.1371/journal.pone.0211438
    [19] Lauritano D, Mastrangelo F, D'Ovidio C, et al. (2023) Activation of mast cells by neuropeptides: The role of pro-inflammatory and anti-inflammatory cytokines. Int J Mol Sci 24: 4811. https://doi.org/10.3390/ijms24054811
    [20] Nishino S, Sakai N, Nishino N, et al. (2022) Brain mast cells in sleep and behavioral regulation. Curr Top Behav Neurosci 59: 427-446. https://doi.org/10.1007/7854_2022_359
    [21] Theoharides TC, Valent P, Akin C (2015) Mast cells, mastocytosis, and related disorders. N Engl J Med 373: 163-172. https://doi.org/10.1056/NEJMra1409760
    [22] Leguit RJ, Wang SA, George TI, et al. (2023) The international consensus classification of mastocytosis and related entities. Virchows Arch 482: 99-112. https://doi.org/10.1007/s00428-022-03423-3
    [23] Gülen T, Akin C, Bonadonna P, et al. (2021) Selecting the right criteria and proper classification to diagnose mast cell activation syndromes: A critical review. J Allergy Clin Immunol Pract 9: 3918-3928. https://doi.org/10.1016/j.jaip.2021.06.011
    [24] Valent P, Hartmann K, Bonadonna P, et al. (2022) Mast cell activation syndromes: Collegium internationale allergologicum update. Int Arch Allergy Immunol 183: 693-705. https://doi.org/10.1159/000524532
    [25] Hellman L, Akula S, Fu Z, et al. (2022) Mast cell and basophil granule proteases - In Vivo targets and function. Front Immunol 13: 918305. https://doi.org/10.3389/fimmu.2022.918305
    [26] Bian G, Gu Y, Xu C, et al. (2021) Early development and functional properties of tryptase/chymase double-positive mast cells from human pluripotent stem cells. J Mol Cell Biol 13: 104-115. https://doi.org/10.1093/jmcb/mjaa059
    [27] Komi DEA, Rambasek T, Wöhrl S (2018) Mastocytosis: From a molecular point of view. Clin Rev Allergy Immunol 54: 397-411. https://doi.org/10.1007/s12016-017-8619-2
    [28] Irani AA, Schechter NM, Craig SS, et al. (1986) Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 83: 4464-4468. https://doi.org/10.1073/pnas.83.12.4464
    [29] Siddhuraj P, Clausson CM, Sanden C, et al. (2021) Lung mast cells have a high constitutive expression of carboxypeptidase A3 mRNA that is independent from granule-stored CPA3. Cells 10: 309. https://doi.org/10.3390/cells10020309
    [30] Donelan J, Boucher W, Papadopoulou N, et al. (2006) Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci USA 103: 7759-7764. https://doi.org/10.1073/pnas.0602210103
    [31] Mustain WC, Rychahou PG, Evers BM (2011) The role of neurotensin in physiologic and pathologic processes. Curr Opin Endocrinol Diabetes Obes 18: 75-82. https://doi.org/10.1097/MED.0b013e3283419052
    [32] Gaudenzio N, Sibilano R, Marichal T, et al. (2016) Different activation signals induce distinct mast cell degranulation strategies. J Clin Invest 126: 3981-3998. https://doi.org/10.1172/JCI85538
    [33] Cianferoni A (2021) Non-IgE-mediated anaphylaxis. J Allergy Clin Immunol 147: 1123-1131. https://doi.org/10.1016/j.jaci.2021.02.012
    [34] Poto R, Quinti I, Marone G, et al. (2022) IgG autoantibodies against IgE from atopic dermatitis can induce the release of cytokines and proinflammatory mediators from basophils and mast cells. Front Immunol 13: 880412. https://doi.org/10.3389/fimmu.2022.880412
    [35] Wernersson S, Pejler G (2014) Mast cell secretory granules: armed for battle. Nat Rev Immunol 14: 478-494. https://doi.org/10.1038/nri3690
    [36] Lee J, Vadas P (2011) Anaphylaxis: mechanisms and management. Clin Exp Allergy 41: 923-938. https://doi.org/10.1111/j.1365-2222.2011.03779.x
    [37] Lundequist A, Pejler G (2011) Biological implications of preformed mast cell mediators. Cell Mol Life Sci 68: 965-975. https://doi.org/10.1007/s00018-010-0587-0
    [38] Theoharides TC, Kempuraj D, Tagen M, et al. (2007) Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 217: 65-78. https://doi.org/10.1111/j.1600-065X.2007.00519.x
    [39] Morita H, Nakae S, Saito H, et al. (2017) IL-33 in clinical practice: Size matters?. J Allergy Clin Immunol 140: 381-383. https://doi.org/10.1016/j.jaci.2017.03.042
    [40] Zhang B, Weng Z, Sismanopoulos N, et al. (2012) Mitochondria distinguish granule-stored from de novo synthesized tumor necrosis factor secretion in human mast cells. Int Arch Allergy Immunol 159: 23-32. https://doi.org/10.1159/000335178
    [41] Nakao A, Nakamura Y, Shibata S (2015) The circadian clock functions as a potent regulator of allergic reaction. Allergy 70: 467-473. https://doi.org/10.1111/all.12596
    [42] Askenase PW (2005) Mast cells and the mediation of T-cell recruitment in arthritis. N Engl J Med 349: 1294. https://doi.org/10.1056/NEJM200309253491319
    [43] Gordon JR, Galli SJ (1990) Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346: 274-276. https://doi.org/10.1038/346274a0
    [44] Zhang B, Alysandratos KD, Angelidou A, et al. (2011) Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: relevance to atopic dermatitis. J Allergy Clin Immunol 127: 1522-1531.e8. https://doi.org/10.1016/j.jaci.2011.02.005
    [45] Panula P (2021) Histamine receptors, agonists, and antagonists in health and disease. Handb Clin Neurol 180: 377-387. https://doi.org/10.1016/B978-0-12-820107-7.00023-9
    [46] Ahmad S, Varagic J, Groban L, et al. (2014) Angiotensin (1–12); A chymase mediated cellular angiotensin II substrate. Curr Hypertens Res 16: 429-437. https://doi.org/10.1007/s11906-014-0429-9
    [47] He S, Walls AF (1998) The induction of a prolonged increase in microvascular permeability by human mast cell chymase. Eur J Pharmacol 352: 91-98. https://doi.org/10.1016/S0014-2999(98)00343-4
    [48] Wong CK, Ng SSM, Lun SWM, et al. (2009) Signaling mechanisms regulating the activation of human eosinophils by mast-cell-derived Chymase; implications for mast-cell-eosinophil interaction in allergic inflammation. Immunology 126: 579-587. https://doi.org/10.1111/j.1365-2567.2008.02916.x
    [49] Caughey GH (2007) Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 217: 141-154. https://doi.org/10.1111/j.1600-065X.2007.00509.x
    [50] Saarinen JV, Harvima RJ, Naukkarinen A, et al. (2001) The release of histamine is associated with the inactivation of mast cell chymase during immediate allergic wheal reactions in the skin. Clin Exp Allergy 31: 593-601. https://doi.org/10.1046/j.1365-2222.2001.01030.x
    [51] Guilarte M, Sala-Cunill A, Luengo O, et al. (2017) The mast cell contact and coagulation system connection in anaphylaxis. Front Immunol 8: 846. https://doi.org/10.3389/fimmu.2017.00846
    [52] Proud D, Togias A, Nacleiro RM, et al. (1983) Kinins are generated in vivo following airway challenge of allergic individuals with allergen. J Clin Invest 72: 1678-1685. https://doi.org/10.1172/JCI111127
    [53] Stone SF, Brown SG (2012) Mediators released during human anaphylaxis. Curr Allergy Asthma Rev 12: 33-41. https://doi.org/10.1007/s11882-011-0231-6
    [54] Caughey GH (2016) Mast cell proteases as pharmacological targets. Eur J Pharmacol 778: 44-55. https://doi.org/10.1016/j.ejphar.2015.04.045
    [55] Imamura T, Dubin A, Moore W, et al. (1996) Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab Invest 74: 861-870.
    [56] Vadas P, Gold M, Perelman B, et al. (2008) Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 358: 28-35. https://doi.org/10.1056/NEJMoa070030
    [57] Fukuda Y, Kawashima H, Saito K, et al. (2000) Effect of human plasma-type platelet activating factor acetylhydrolase in two anaphylactic shock models. Eur J Pharmacol 390: 203-207. https://doi.org/10.1016/S0014-2999(99)00920-6
    [58] Arimura A, Harada M (1991) Differential effect of a PAF antagonist CV- 3988 on active and passive anaphylactic shock in various mouse strains. Lipids 26: 1386-1390. https://doi.org/10.1007/BF02536572
    [59] Gill P, Jindal NL, Jagdis A, et al. (2015) Platelets in the immune response; Revisiting platelet activating factor in anaphylaxis. J Allergy Clin Immunol 135: 1424-1432. https://doi.org/10.1016/j.jaci.2015.04.019
    [60] Kajiwara N, Sasaki T, Braddind P, et al. (2010) Activation of human mast cells through the platelet-activating factor receptor. J Allergy Clin Immunology 125: 1137-1145. https://doi.org/10.1016/j.jaci.2010.01.056
    [61] Dao VT, Medini S, Bisha M, et al. (2016) Nitric oxide up-regulates endothelial expression of angiotensin II type 2 receptors. Biochem Pharmacol 112: 24-36. https://doi.org/10.1016/j.bcp.2016.05.011
    [62] Mombouli JV, Vanhoutte PM (1992) Heterogeneity of endothelium-dependent vasodilator effects of angiotensin converting enzyme inhibitors: role of bradykinin generation during ACE inhibition. J Cardiovasc Pharmacol 20: S74-S82. https://doi.org/10.1097/00005344-199200209-00014
    [63] Lowenstein CJ, Michel T (2006) What's in a name? eNOS and anaphylactic shock. J Clin Invest 116: 2075-2078. https://doi.org/10.1172/JCI29406
    [64] Kuehn HS, Radinger M, Gilfillan AM (2010) Measuring mast cell mediator release. Curr Protoc Immunol 2 Chapter 7: Unit 7.38. https://doi.org/10.1002/0471142735.im0738s91
    [65] Nguyen SMT, Rupprecht CP, Haque A, et al. (2021) Mechanisms governing anaphylaxis: inflammatory cells, mediators, endothelial gap junctions and beyond. Int J Mol Sci 22: 7785. https://doi.org/10.3390/ijms22157785
    [66] Dileepan KN, Raveendran VV, Sharma R (2023) Mast cell-mediated immune regulation in health and disease. Front Med (Lausanne) 10: 1213320. https://doi.org/10.3389/fmed.2023.1213320
    [67] Mukai K, Tsai M, Saito, et al. (2018) Mast cells as sources of cytokines, chemokines, and growth factors. Immunol Rev 282: 121-150. https://doi.org/10.1111/imr.12634
    [68] Noordenbos T, Blijdorp I, Chen S, et al. (2016) D. Human mast cells capture, store, and release bioactive, exogenous IL-17A. J Leukoc Biol 100: 453-462. https://doi.org/10.1189/jlb.3HI1215-542R
    [69] Moulin D, Donzé O, Talabot-Ayer D, et al. (2007) Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40: 216-225. https://doi.org/10.1016/j.cyto.2007.09.013
    [70] Saluja R, Ketelaar ME, Hawro T, et al. (2015) The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders. Mol Immunol 63: 80-85. https://doi.org/10.1016/j.molimm.2014.06.018
    [71] Silver MR, Margulis A, Wood N, et al. (2010) IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation. Inflamm Res 59: 207-218. https://doi.org/10.1007/s00011-009-0088-5
    [72] Kandere-Grzybowska K, Letourneau R, Kempuraj D, et al. (2003) IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol 171: 4830-4836. https://doi.org/10.4049/jimmunol.171.9.4830
    [73] Theoharides TC, Zhang B, Kempuraj D, et al. (2010) IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci USA 107: 4448-4453. https://doi.org/10.1073/pnas.1000803107
    [74] Petra AI, Tsilioni I, Taracanova A, et al. (2018) Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E. Allergy Asthma Proc 39: 153-160. https://doi.org/10.2500/aap.2018.38.4105
    [75] Salamon P, Shoham NG, Gavrieli R, et al. (2005) Human mast cells release Interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells. Allergy 60: 1316-1319. https://doi.org/10.1111/j.1398-9995.2005.00886.x
    [76] Sumpter TL, Ho CH, Pleet AR, et al. (2015) Autocrine hemokinin-1 functions as an endogenous adjuvant for IgE-mediated mast cell inflammatory responses. J Allergy Clin Immunol 135: 1019-1030.e8. https://doi.org/10.1016/j.jaci.2014.07.036
    [77] Conti P, Caraffa Al, Kritas SK, et al. (2017) Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues. J Biol Regul Homeost Agents 31: 263-267.
    [78] Bruhns P, Chollet-Martin S (2021) Mechanisms of human drug-induced anaphylaxis. J Allergy Clin Immunol 147: 1133-1142. https://doi.org/10.1016/j.jaci.2021.02.013
    [79] Zhang B, Li Q, Shi C, et al. (2018) Drug-induced pseudoallergy: A review of the causes and mechanisms. Pharmacology 101: 104-110. https://doi.org/10.1159/000479878
    [80] Yu Y, Blokhuis BR, Garssen J, et al. (2016) Non-IgE mediated mast cell activation. Eur J Pharmacol 778: 33-43. https://doi.org/10.1016/j.ejphar.2015.07.017
    [81] Cao J, Papadopoulou N, Kempuraj D, et al. (2005) Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol 174: 7665-7675. https://doi.org/10.4049/jimmunol.174.12.7665
    [82] Caceda R, Kinkead B, Nemeroff CB (2006) Neurotensin: role in psychiatric and neurological diseases. Peptides 27: 2385-2404. https://doi.org/10.1016/j.peptides.2006.04.024
    [83] Lazarus LH, Perrin MH, Brown MR, et al. (1977) Verification of both the sequence and conformational specificity of neurotensin in binding to mast cells. Biochem Biophys Res Commun 76: 1079-1085. https://doi.org/10.1016/0006-291X(77)90966-4
    [84] Theoharides TC (2017) Neuroendocrinology of mast cells: challenges and controversies. Exp Dermatol 26: 751-759. https://doi.org/10.1111/exd.13288
    [85] Theoharides TC, Cochrane DE (2004) Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 146: 1-12. https://doi.org/10.1016/j.jneuroim.2003.10.041
    [86] McNeil BD, Pundir P, Meeker S, et al. (2015) Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature 519: 237-241. https://doi.org/10.1038/nature14022
    [87] Kolkhir P, Elieh-Ali-Komi D, Metz M, et al. (2022) Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases. Nat Rev Immunol 22: 294-308. https://doi.org/10.1038/s41577-021-00622-y
    [88] Yoo HS, Yang EM, Kim MA, et al. (2014) A case of codeine induced anaphylaxis via oral route. Allergy Asthma Immunol Res 6: 95-97. https://doi.org/10.4168/aair.2014.6.1.95
    [89] Casale TB, Bowman S, Kaliner M (1984) Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation. J Allergy Clin Immunol 73: 775-781. https://doi.org/10.1016/0091-6749(84)90447-0
    [90] Logothetidis S (2014) Nanomedicine and Nanobiotechnology. Berlin, Heidelberg: Springer. Available from: https://doi.org/10.1007/978-3-642-24181-9
    [91] Dézsi L, Fülöp T, Mészáros T, et al. (2014) Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses. J Control Release 195: 2-10. https://doi.org/10.1016/j.jconrel.2014.08.009
    [92] Drouin SM, Kildsgaard J, Haviland J, et al. (2001) Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol 166: 2025-2032. https://doi.org/10.4049/jimmunol.166.3.2025
    [93] Hartmann K, Henz BM, Krüger-Krasagakes S, et al. (1997) C3a and C5a stimulate chemotaxis of human mast cells. Blood 89: 2863-2870. https://doi.org/10.1182/blood.V89.8.2863
    [94] Kanagaratham C, El Ansari YS, Lewis OL, et al. (2020) IgE and IgG antibodies as regulators of mast cell and basophil functions in food allergy. Front Immunol 11: 603050. https://doi.org/10.3389/fimmu.2020.603050
    [95] Nimmerjahn F, Bruhns P, Horiuchi K, et al. (2005) Fcgamma RIV: a novel FcR with distinct IgG subclass specificity. Immunity 23: 41-51. https://doi.org/10.1016/j.immuni.2005.05.010
    [96] Bruhns P, Jonsson F (2015) Mouse and human FcR effector functions. Immunol Rev 268: 25-51. https://doi.org/10.1111/imr.12350
    [97] Nimmerjahn F, Ravetch JV (2008) Fc gamma receptors as regulators of immune responses. Nat Rev Immunol 8: 34-47. https://doi.org/10.1038/nri2206
    [98] Nimmerjahn F, Ravetch JV (2006) Fcgamma receptors: old friends and new family members. Immunity 24: 19-28. https://doi.org/10.1016/j.immuni.2005.11.010
    [99] Cocchiara R, Albeggiani G, Di Trapani G (1990) Modulation of rat peritoneal mast cell and human basophil histamine release by estrogens. Int Arch Allergy Appl Immunol 93: 192-197. https://doi.org/10.1159/000235300
    [100] Nakasato H, Ohrui T, Sekizawa K (1999) Prevention of severe premenstrual asthma attacks by leukotriene receptor antagonist. J Allergy Clin Immunol 104: 585-588. https://doi.org/10.1016/S0091-6749(99)70327-1
    [101] Vliagoftis H, Dimitriadou V, Boucher W, et al. (1992) Estradiol augments while tamoxifen inhibits rat mast cell secretion. Int Arch Allergy Immunol 98: 398-409. https://doi.org/10.1159/000236217
    [102] Vrieze A, Postma DS, Kerstjens HA (2003) Perimenstrual asthma: a syndrome without known cause or cure. J Allergy Clin Immunol 112: 271-282. https://doi.org/10.1067/mai.2003.1676
    [103] Zaitsu M, Narita S, Lambert KC, et al. (2007) Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol 44: 1977-1985. https://doi.org/10.1016/j.molimm.2006.09.030
    [104] Howard PJ, Ambrosuis WT, Tewksbury DA, et al. (1998) Serum Angiotensinogen concentration in relation to gonadal hormones, body size and genotype in growing young people. Hypertension 32: 875-879. https://doi.org/10.1161/01.HYP.32.5.875
    [105] Giacchetti G, Faloia E, Mariniello B, et al. (2002) Over expression of the renin angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertension 15: 381-388. https://doi.org/10.1016/S0895-7061(02)02257-4
    [106] Reinholz M, Ruzicka T, Schauber J (2012) Vitamin D and its role in allergic disease. Clin Exp Allergy 42: 817-826. https://doi.org/10.1111/j.1365-2222.2011.03923.x
    [107] Agrawal T, Gupta GK, Agrawal DK (2013) Vitamin D supplementation reduces airway hyperresponsiveness and allergic airway inflammation in a murine model. Clin Exp Allergy 43: 672-683. https://doi.org/10.1111/cea.12102
    [108] Aranow C (2011) Vitamin D and the immune system. J Investig Med 59: 881-886. https://doi.org/10.2310/JIM.0b013e31821b8755
    [109] Hewison M (2010) Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 39: 365-379. https://doi.org/10.1016/j.ecl.2010.02.010
    [110] Norman AW, Mizwicki MT, Norman DP (2004) Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3: 27-41. https://doi.org/10.1038/nrd1283
    [111] Mahon BD, Wittke A, Weaver V, et al. (2003) The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89: 922-932. https://doi.org/10.1002/jcb.10580
    [112] Fabri M, Stenger S, Shin DM, et al. (2011) Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med 3: 104ra102. https://doi.org/10.1126/scitranslmed.3003045
    [113] Gupta A, Dimeloe S, Richards DF, et al. (2014) Defective IL-10 expression and in vitro steroid-induced IL-17A in paediatric severe therapy-resistant asthma. Thorax 69: 508-515. https://doi.org/10.1136/thoraxjnl-2013-203421
    [114] Herman K, Ring J (1990) Hymenoptera venom anaphylaxis: may decrease levels of angiotensin peptides play a role?. Clin Exp All 20: 569-570. https://doi.org/10.1111/j.1365-2222.1990.tb03151.x
    [115] Herman K, Ring J (1993) The renin angiotensin system and hymenoptera venom anaphylaxis. Clin Exp Allergy 23: 762-769. https://doi.org/10.1111/j.1365-2222.1993.tb00364.x
    [116] Summers CW, Pumphrey RS, Woods CN, et al. (2008) Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist centre. J Allergy Clin Immunol 121: 632-638. https://doi.org/10.1016/j.jaci.2007.12.003
    [117] Slade CA, Douglass JA (2014) Changing practice: no need to stop ACE inhibitors for venom immunotherapy. Clin Exp Allergy 44: 617-619. https://doi.org/10.1111/cea.12295
    [118] Varney VA, Warner A, Ghosh A, et al. (2012) IgE mediated anaphylaxis to foods, venom, and drugs; influence of serum angiotensin converting enzyme levels and genotype. J Allergy (Cairo) 2012: 258145. https://doi.org/10.1155/2012/258145
    [119] Niedoszytko M, Ratajska M, Jassem E (2007) AGT(M235T), ACE(I/D, I/I, D/D) polymorphism in patients with insect venom allergy preliminary results. Allergy 62: 111.
    [120] Mueller UR (1990) Clinical presentation and pathogenesis. Insect sting allergy . Stuttgart: Gustav Fischer 33-65.
    [121] Dimitropoulou C, Chatterjee A, McCloud L (2006) Angiotensin, bradykinin and the endothelium. The Vascular Endothelium I. Handbook of Experimental Pharmacology . Berlin, Heidelberg: Springer 255-294. https://doi.org/10.1007/3-540-32967-6_8
    [122] Varney VA, Nicholas A, Warner A, et al. (2019) IgE-mediated systemic anaphylaxis and its association with gene polymorphisms of ACE, angiotensinogen and chymase. J Asthma Allergy 12: 343-361. https://doi.org/10.2147/JAA.S213016
    [123] Nisho H, Takai S, Miyazaki M, et al. (2005) Usefulness of serum mast cells specific chymase levels for postmortem diagnosis of anaphylaxis. Int J Legal Med 119: 331-334. https://doi.org/10.1007/s00414-005-0524-1
    [124] Zhou X, Whitworth HS, E-Khedr M, et al. (2011) Mast cell chymase: a useful marker in anaphylaxis. J Allergy Clin Immunol 127: 990-997. https://doi.org/10.1016/j.jaci.2011.01.057
    [125] Gulen T, Akin C (2021) Idiopathic anaphylaxis: a perplexing diagnostic challenge for allergists. Curr Allergy Asthma Rep 21: 11. https://doi.org/10.1007/s11882-021-00988-y
    [126] Akin C (2014) Mast cell activation disorders. J Allergy Clin Immunol Pract 2: 252-257. https://doi.org/10.1016/j.jaip.2014.03.007
    [127] Metcalfe DD, Peavy RD, Gilfillan AM (2009) Mechanisms of mast cell signaling in anaphylaxis. J Allergy Clin Immunol 124: 639-646. https://doi.org/10.1016/j.jaci.2009.08.035
    [128] Gulen T, Hagglund H, Dahlen SE, et al. (2014) Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis. Lancet 383: 1608. https://doi.org/10.1016/S0140-6736(14)60585-7
    [129] Valent P, Akin C, Arock M, et al. (2012) Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol 157: 215-225. https://doi.org/10.1159/000328760
    [130] Nakamura Y, Nakano N, Ishimaru K, et al. (2016) Inhibition of IgE-mediated allergic reactions by pharmacologically targeting the circadian clock. J Allergy Clin Immunol 137: 1226-1235. https://doi.org/10.1016/j.jaci.2015.08.052
    [131] Kristensen T, Vestergaard H, Bindslev-Jensen C, et al. (2014) Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis. Am J Hematol 89: 493-498. https://doi.org/10.1002/ajh.23672
    [132] Bonadonna P, bonifacio M, Lambarderdo C, et al. (2015) Hymenoptera anaphylaxis and C-KIT Mutations: An unexpected association. Curr Allergy Asthma Rep 15: 49. https://doi.org/10.1007/s11882-015-0550-0
    [133] Sonneck K, Florian S, Mullauer L, et al. (2007) Diagnostic and sub-diagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome. Int Arch Allergy Immunol 142: 158-164. https://doi.org/10.1159/000096442
    [134] Valent P, Akin C, Bonadonna P, et al. (2019) Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome. J Allergy Clin Immunol Pract 7: 1125-1133. https://doi.org/10.1016/j.jaip.2019.01.006
    [135] Gulen T, Hagglund H, Dahlen B, et al. Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease. J Intern Med 279: 211-228. https://doi.org/10.1111/joim.12410
    [136] Valent P, Akin C, Metcalfe DD (2016) Mastocytosis 2016: updated WHO classification and novel emerging treatment concepts. Blood 129: 1420-1427. https://doi.org/10.1182/blood-2016-09-731893
    [137] Gotlib J, Kluin-Nelemans HC, George TI, et al. (2016) Efficacy and safety of midostaurin in advanced systemic mastocytosis. N Engl J Med 374: 2530-2541. https://doi.org/10.1056/NEJMoa1513098
    [138] Fuchs D, Kilbertus A, Kofler K, et al. (2021) Scoring the risk of having systemic mastocytosis in adult patients with mastocytosis in the skin. J Allergy Clin Immunol Pract 9: 1705-1712.e4. https://doi.org/10.1016/j.jaip.2020.12.022
    [139] Kennedy VE, Perkins C, Reiter A, et al. (2023) Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry. Blood Adv 7: 1713-1724. https://doi.org/10.1182/bloodadvances.2022008292
    [140] Gulen T, Ljung C, Nilsson G, et al. (2017) Risk factor analysis of anaphylactic reactions in patients with systemic mastocytosis. J Allergy Clin Immunol Pract 5: 1248-1255. https://doi.org/10.1016/j.jaip.2017.02.008
    [141] Gulen T, Hagglund H, Dahlen B, et al. (2014) High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience. Clin Exp Allergy 44: 121-129. https://doi.org/10.1111/cea.12225
    [142] Monaco A, Choi D, Uzun S, et al. (2022) Association of mast-cell-related conditions with hypermobile syndromes: a review of the literature. Immunol Res 70: 419-431. https://doi.org/10.1007/s12026-022-09280-1
    [143] Sumantri S, Rengganis I (2023) Immunological dysfunction and mast cell activation syndrome in long COVID. Asia Pac Allergy 13: 50-53. https://doi.org/10.5415/apallergy.0000000000000022
    [144] Voelker D, Pongdee T (2014) Urine mast cell mediators in the evaluation and diagnosis of mast cell activation syndrome. Curr Allergy Asthma Rep 24: 33-38. https://doi.org/10.1007/s11882-024-01128-y
    [145] Zhu L, Jian X, Zhou B, et al. (2024) Gut microbiota facilitate chronic spontaneous urticaria. Nat Commun 15: 112. https://doi.org/10.1038/s41467-023-44373-x
    [146] Robey RC, Wilcock A, Bonin H, et al. (2020) Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression. J Allergy Clin Immunol Pract 8: 3549-3556. https://doi.org/10.1016/j.jaip.2020.05.057
    [147] Chollet MB, Akin C (2021) Hereditary alpha tryptasemia is not associated with specific clinical phenotypes. J Allergy Clin Immunol 148: 889-894. https://doi.org/10.1016/j.jaci.2021.06.017
    [148] Butterfield JH, Ravi A, Pongdee T (2018) Mast cell mediators of significance in clinical practice in mastocytosis. Immunol Allergy Clin North Am 38: 397-410. https://doi.org/10.1016/j.iac.2018.04.011
    [149] Lyons JJ, Sun G, Stone KD, et al. (2014) Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities. J Allergy Clin Immunol 133: 1471-1474. https://doi.org/10.1016/j.jaci.2013.11.039
    [150] Lyons JJ, Yu X, Hughes JD, et al. (2016) Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nat Genet 48: 1564-1569. https://doi.org/10.1038/ng.3696
    [151] Simons FE, Ardusso LR, Bilo MB, et al. (2011) World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 4: 13-37. https://doi.org/10.1097/WOX.0b013e318211496c
    [152] Braganza SC, Acworth JP, McKinnon DR, et al. (2006) Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 91: 159-163. https://doi.org/10.1136/adc.2004.069914
    [153] Muraro A, Roberts G, Worm M, et al. (2014) Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 69: 1026-1045. https://doi.org/10.1111/all.12437
    [154] Jarkvist J, Salehi C, Akin C, et al. (2020) Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection. Allergy 75: 169-177. https://doi.org/10.1111/all.13980
    [155] Broesby-Olsen S, Vestergaard H, Mortz CG, et al. (2018) Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: efficacy and safety observations. Allergy 73: 230-238. https://doi.org/10.1111/all.13237
    [156] Gotlib J, Kluin-Nelemans HC, Akin C, et al. (2021) Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurin. Expert Opin Biol Ther 21: 487-498. https://doi.org/10.1080/14712598.2021.1837109
    [157] Gotlib J, Kluin-Nelemans HC, George TI, et al. (2016) Efficacy and safety of midostaurin in advanced systemic mastocytosis. N Engl J Med 374: 2530-2541. https://doi.org/10.1056/NEJMoa1513098
    [158] Kudlaty E, Perez M, Stein BL, et al. (2021) Systemic mastocytosis with an associated hematologic neoplasm complicated by recurrent anaphylaxis: prompt resolution of anaphylaxis with the addition of avapritinib. J Allergy Clin Immunol Pract 9: 2534-2536. https://doi.org/10.1016/j.jaip.2021.02.040
  • This article has been cited by:

    1. Fengjiao Zhang, Yinfang Song, Chao Wang, α-Synchronization of a Class of Unbounded Delayed Inertial Cohen–Grossberg Neural Networks with Delayed Impulses, 2023, 11, 2227-7390, 4096, 10.3390/math11194096
    2. Xinyi He, Xiuping Han, Tengda Wei, Xiaodi Li, Tracking control of wheeled mobile robots via intermittent control, 2024, 21, 1551-0018, 3774, 10.3934/mbe.2024167
    3. Gani Stamov, Ivanka Stamova, Cvetelina Spirova, On an Impulsive Conformable M1 Oncolytic Virotherapy Neural Network Model: Stability of Sets Analysis, 2025, 13, 2227-7390, 141, 10.3390/math13010141
    4. Ivanka Stamova, Gani Stamov, 2025, 9780443301346, 159, 10.1016/B978-0-44-330134-6.00011-1
    5. Ivanka Stamova, Gani Stamov, 2025, 9780443301346, 1, 10.1016/B978-0-44-330134-6.00008-1
    6. 2025, 9780443301346, 303, 10.1016/B978-0-44-330134-6.00012-3
  • Reader Comments
  • © 2024 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(1804) PDF downloads(97) Cited by(1)

Figures and Tables

Figures(1)  /  Tables(2)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog